Viewing Study NCT04870112


Ignite Creation Date: 2025-12-26 @ 10:45 PM
Ignite Modification Date: 2025-12-26 @ 10:45 PM
Study NCT ID: NCT04870112
Status: TERMINATED
Last Update Posted: 2025-04-17
First Post: 2021-04-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module